HomeBGLC • NASDAQ
add
BioNexus Gene Lab Corp
Previous close
$5.05
Day range
$5.10 - $5.24
Year range
$2.01 - $15.60
Market cap
9.35M USD
Avg Volume
130.58K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 2.26M | 14.47% |
Operating expense | 990.45K | 652.14% |
Net income | -616.17K | -409.47% |
Net profit margin | -27.26 | -370.44% |
Earnings per share | — | — |
EBITDA | -594.63K | -435.49% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.06M | -43.50% |
Total assets | 9.42M | -15.43% |
Total liabilities | 1.90M | 19.15% |
Total equity | 7.52M | — |
Shares outstanding | 1.80M | — |
Price to book | 1.20 | — |
Return on assets | -16.47% | — |
Return on capital | -19.79% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -616.17K | -409.47% |
Cash from operations | -737.91K | -9.76% |
Cash from investing | -28.53K | -145.07% |
Cash from financing | -1.03K | -100.59% |
Net change in cash | -552.25K | -15.90% |
Free cash flow | -550.93K | 25.94% |
About
Founded
2017
Website
Employees
30
